Dr Neal Navani, Consultant Respiratory Physician
Private diagnosis, treatment and care for all types of respiratory illness
Dr Navani is a busy Respiratory Medicine Consultant at University College London Hospital (UCLH), which is an internationally recognised centre of excellence. He also sees private patients at The Physicians’ Clinic and at the King Edward VII Hospital, one of the foremost private hospitals in central London. Dr Navani is also available for eConsultations for private patients in the UK and internationally.
Dr Navani’s clinical practice at both centres involves treating patients with common conditions such as chronic cough, asthma and smoking-related lung disease including chronic obstructive pulmonary disease (COPD). He is also an expert in managing lung cancer and also lung problems in patients with other cancers.
Dr Navani’s specialties include
- Investigating and treating chronic cough
- Screening at-risk patients for early stage lung cancer using the latest techniques
- Using endobronchial ultrasound as a tool for diagnosing respiratory conditions
Dr Navani developed the endobronchial ultrasound service at UCLH and he is one of the leading world experts in this area of respiratory diagnostics. He has lectured around the world on the diagnosis of lung conditions including lung cancer.
Dr Navani is Chair of the Lung Cancer Service at University College London Hospital and Clinical Director for lung cancer services across London. He is one of the authors of the 2019 National NICE guideline for lung cancer and was appointed as Clinical Lead at the Royal College of Physicians for measuring standards of lung cancer care in 2016.
Dr Navani diagnoses and treats:
- Pneumonia and lung infections
- Acute and chronic bronchitis
- Lung fibrosis
- Lung cancer
- Pulmonary embolism
No smoking symbol: the UK banned smoking in public plac…
The National Health Service in the UK does not currently perform lung cancer screening but it is available in the p…
The Global Adult Tobacco Survey took a detailed look at adult tobacco use in 14 low and middle-income countries….